2020
Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses
Wallach JD, Wang K, Zhang AD, Cheng D, Grossetta Nardini HK, Lin H, Bracken MB, Desai M, Krumholz HM, Ross JS. Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses. The BMJ 2020, 368: l7078. PMID: 32024657, PMCID: PMC7190063, DOI: 10.1136/bmj.l7078.Peer-Reviewed Original ResearchConceptsIndividual patient-level dataCardiovascular related deathsCardiovascular riskMyocardial infarctionRelated deathsSummary-level dataHeart failureOdds ratioSystematic reviewIncreased cardiovascular riskMore myocardial infarctionsHeart failure eventsCochrane Central RegistryAcute myocardial infarctionMyocardial infarction eventsPatient-level dataRandom-effects modelWeb of ScienceAnalysis of trialsEligible trialsComposite outcomeAdverse eventsContinuity correctionControlled TrialsRosiglitazone treatment
2018
Interventions to treat cutaneous leishmaniasis in children: A systematic review
Uribe-Restrepo A, Cossio A, Desai MM, Dávalos D, del Mar Castro M. Interventions to treat cutaneous leishmaniasis in children: A systematic review. PLOS Neglected Tropical Diseases 2018, 12: e0006986. PMID: 30550538, PMCID: PMC6310290, DOI: 10.1371/journal.pntd.0006986.Peer-Reviewed Original ResearchConceptsInternational Clinical Trials Registry PlatformAdverse eventsMeglumine antimoniateCutaneous leishmaniasisSystematic reviewClinical trialsManagement of CLClinical Trials Registry PlatformOld World cutaneous leishmaniasisTreatment of CLIntralesional meglumine antimoniateOld World CLEfficacy of cryotherapySerious adverse eventsTrials Registry PlatformHarms of interventionsRisk of biasEfficacy of treatmentFull-text reviewAmerican cutaneous leishmaniasisPROSPERO International registerRegistry PlatformCohort studySystemic therapyPediatric population
2015
The Value of Continuous ST-Segment Monitoring in the Emergency Department
Bovino LR, Funk M, Pelter MM, Desai MM, Jefferson V, Andrews LK, Forte K. The Value of Continuous ST-Segment Monitoring in the Emergency Department. Advanced Emergency Nursing Journal 2015, 37: 290-300. PMID: 26509726, PMCID: PMC4644066, DOI: 10.1097/tme.0000000000000080.Peer-Reviewed Original ResearchConceptsContinuous ST-segment monitoringAcute coronary syndromeST-segment monitoringEmergency departmentAdverse eventsDiagnostic accuracyRisk-stratified analysisLikelihood ratioSingle emergency departmentHigh-risk participantsCoronary syndromeElectrocardiographic monitoringMedian timeTroponin (HEART) scoreMyocardial ischemiaRisk factorsHigh riskDiagnostic benefitIschemiaIntervention phaseDiagnosisBedside monitorsInfarctionPatientsSymptoms
2012
Short-Term Outcomes of Ablation Therapy for Hepatic Tumors: Evidence from the 2006–2009 Nationwide Inpatient Sample
Fox JP, Gustafson J, Desai MM, Hellan M, Thambi-Pillai T, Ouellette J. Short-Term Outcomes of Ablation Therapy for Hepatic Tumors: Evidence from the 2006–2009 Nationwide Inpatient Sample. Annals Of Surgical Oncology 2012, 19: 3677-3686. PMID: 22588470, DOI: 10.1245/s10434-012-2397-0.Peer-Reviewed Original ResearchConceptsProcedure-specific complicationsNationwide Inpatient SampleMetastatic liver tumorsOpen surgical approachHepatic tumorsPostoperative complicationsSurgical approachInpatient SampleLiver tumorsMultivariable logistic regression analysisTreatment-related morbidityCases/yearLogistic regression analysisResultsMost patientsTransfusion requirementsHospital morbidityAdverse eventsIntraoperative bleedingBackgroundRadiofrequency ablationHeart failureHepatic failurePatient factorsTerm outcomesLaparoscopic proceduresAblation therapy